Stay updated on Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedThe Locations section now lists Beijing Municipality and Shanghai Municipality under Locations, and the revision version updated to v3.3.3.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed, a public database, and the revision note updates the page version from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check38 days agoChange DetectedThe government funding notice about potential delays and operating status has been removed from the page.SummaryDifference0.4%

- Check53 days agoChange DetectedCosmetic updates to layout and styling are visible, with no changes to core study information such as the title, conditions, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check81 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference3%

- Check88 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.